Corporate Banner
Satellite Banner
Technology Networks Header
Friday, November 28, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Rigaku Corporation Presents the Smart Sample Loading System
Thursday, March 20, 2014
New system for use on Company’s ZSX Primus wavelength dispersive X-ray spectrometers.

Malvern Scientists Present Emerging Protein Characterization Techniques
Tuesday, March 18, 2014
Dr Wei Qi and Dr Linda Kidder will present their work at the 2014 Biotherapeutics Analytical Summit.

TI Announces First NIR DLP® Device and DLP NIRscan™ EVM
Tuesday, March 11, 2014
New products can enable programmable, portable NIR spectrometers that can significantly reduce system costs.

Bio-Rad Announces New Technology for the Identification of Unknown Compounds
Thursday, March 06, 2014
KnowItAll® ATR/IR ID Expert™ and Raman ID Expert™ Solutions from Bio-Rad.

RCMP to Use Bio-Rad's KnowItAll® Spectroscopy Software
Thursday, March 06, 2014
RCMP use KnowItAll software for analysis of automobile crime scene samples.

Malvern Announces Guest Presenter for March 18th Protein Characterization Webinar
Thursday, March 06, 2014
Renowned protein scientist Prof. Dr. John F. Carpenter shows how combining DLS with Raman Spectroscopy delivers new insights in protein stability, aggregation and structure.

Rigaku Unveils New Progeny Material ID Handheld Raman Analyzer
Wednesday, March 05, 2014
Redefines performance, ruggedness and ease-of-use.

ART Presents Latest EDXRF Instrumentation at Pittcon 2014
Tuesday, March 04, 2014
65th annual Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy held March 2 - 6, 2014 in USA.

Agilent Technologies Introduces Innovative Handheld FTIR Spectrometer
Tuesday, March 04, 2014
4300 Handheld FTIR Features Ergonomic Design, Ease of Use; Live Product Demos, Webinars on March 11, 25.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 533
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv